100 related articles for article (PubMed ID: 8625523)
1. Effect of intrajejunal elemental diet perfusion on local secretion of soluble CD4 and CD8.
Desreumaux P; Levy A; Vaerman JP; Capron M; Cortot A; Colombel JF
Clin Exp Immunol; 1996 May; 104(2):293-6. PubMed ID: 8625523
[TBL] [Abstract][Full Text] [Related]
2. Effect of intrajejunal elemental diet perfusion on jejunal secretion of immunoglobulins, albumin, and hyaluronan in man.
Colombel JF; Vaerman JP; Hällgren R; Dehennin JP; Wain E; Modigliani R; Cortot A
Gut; 1992 Jan; 33(1):44-7. PubMed ID: 1740276
[TBL] [Abstract][Full Text] [Related]
3. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.
Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N
Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
5. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome.
Sawada S; Sugai S; Iijima S; Takei M; Paredes E; Hayama T; Nishinarita S; Hosokawa Y; Horie T; Obara T
Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196
[TBL] [Abstract][Full Text] [Related]
6. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble CD4 and CD8 levels in Kawasaki disease.
Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
[TBL] [Abstract][Full Text] [Related]
8. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
[TBL] [Abstract][Full Text] [Related]
9. Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus.
Sawada S; Hashimoto H; Iijima S; Tokano Y; Takei M; Shida M; Obara T
J Clin Lab Anal; 1993; 7(3):141-6. PubMed ID: 8509943
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.
Vitale G; Mocciaro C; Malta R; Gambino G; Spinelli A; Giordano C; Stassi G; Arcoleo F; Milano S; Cillari E
Clin Exp Immunol; 1994 Aug; 97(2):280-3. PubMed ID: 8050177
[TBL] [Abstract][Full Text] [Related]
11. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
Mansueto S; Vitale G; Mocciaro C; Gambino G; Colletti P; Mansueto P; Spinelli A; Affronti M; Chifari N; Arcoleo F; Milano S; Cillari E
Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
13. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities.
Sun CC; Wu J; Wong TT; Wang LF; Chuan MT
Br J Dermatol; 2000 Dec; 143(6):1235-40. PubMed ID: 11122027
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD4 and CD8 molecules in patients with systemic sclerosis.
Tokano Y; Kaneko H; Obara T; Hashimoto H; Okumura K; Hirose S
Clin Rheumatol; 1993 Dec; 12(4):490-3. PubMed ID: 8124911
[TBL] [Abstract][Full Text] [Related]
15. Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell activity.
Weiss C; Wulf G; Ho AD; Hunstein W
Immunol Lett; 1991 Sep; 30(1):113-8. PubMed ID: 1683649
[TBL] [Abstract][Full Text] [Related]
16. Immune function in patients with acute pancreatitis.
Uehara S; Gothoh K; Handa H; Tomita H; Tomita Y
J Gastroenterol Hepatol; 2003 Apr; 18(4):363-70. PubMed ID: 12653883
[TBL] [Abstract][Full Text] [Related]
17. [Soluble lymphocyte antigens in hematological diseases].
Yoneyama A; Higashihara M; Nakahara K
Rinsho Ketsueki; 1995 Apr; 36(4):286-92. PubMed ID: 7783331
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD4, CD8 in patients with polymyositis/dermatomyositis.
Tokano Y; Obara T; Hashimoto H; Okumura K; Hirose S
Clin Rheumatol; 1993 Sep; 12(3):368-74. PubMed ID: 8258239
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the accuracy of segmental perfusion under an occluding balloon for measuring the intrajejunal secretion of albumin and immunoglobulin A.
Rambaud JC; Duprey F; Nouel O; Hostein J; Delpech B; Bernier JJ
Gut; 1981 May; 22(5):371-5. PubMed ID: 6788656
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD4 and CD8 in serum from patients with localized scleroderma.
Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K
Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
